Patheon expands reach of soft-gel caps; Almac boasts of successful MHRA inspections;

> Patheon has teamed with PROCAPS in Columbia to provide P-Gels soft-gel capsulation manufacturing services worldwide. Release

> Almac's sciences business unit is boasting successful MHRA inspections at its Craigavon, Ireland HQ plant and Elvingston, Scotland sites. Release

> CMO Pharmaceutics International has begun construction of a 24,000-square-foot GMP aseptic fill/finish manufacturing facility at its Hunt Valley, MD, campus. Release

> Frost & Sullivan anticipates more than a doubling of contract manufacturing revenue in Europe, to $20.8 billion in 2018. Announcement

> Massachusetts biotechs are targeting the biosimilars market. Story

> India has extended its January deadline for secondary-packaging barcoding on drug exports to this coming July; the primary-packaging deadline was pushed to January 2013. Story

> Generics giant Teva ($TEVA) has "rationalized" logistics with a custom plastic pallet from Dolav.  Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.